Ministers promise fresh procurement, but critics warn extension gives US supplier more time to dig in.

Lawmakers and campaign groups have slammed the UK government's decision to extend Palantir's controversial NHS contract by two years.

Health minister James Frith told MPs on Monday that the current contract would continue until March 2029 as the government procures a newly introduced version of the Federated Data Platform (FDP). The existing Palantir-led deal, awarded in 2023, has a maximum value of ยฃ330 million and includes other suppliers.

Frith stated the new procurement would focus on interoperability, resilience, and trusted common standards in a "new FDP iteration" which would "welcome international and UK capability alike โ€“ whether that is UK small and medium-sized enterprises that want a crack at NHS contracts, sovereign AI-backed capability in the UK or any international provider worth merit.".

Palantir's cornerstone NHS contract win attracted criticism for lack of transparency. The US supplier had already won ยฃ60 million in NHS contracts without competition during and following the pandemic. Use cases from this period were carried over to the FDP. Critics have also challenged the evidence used to promote the FDP's claimed benefits.

Industry observers note that dame Chi Onwurah, chair of the Commons Science and Technology Committee, mentioned she was "extremely disappointed" by the decision. She challenged the government's reliance on continuity of care to justify keeping the contract, given its existing transition provisions. She said Palantir made it clear it would use the next two years to "embed itself even more deeply in our public services.".

"If a break clause cannot be exercised because of continuity of care, it is not a break clause; it is a lock-in. The Minister assured me that there were already contractual requirements that smooth continuity of care should continue. Were those assurances made in error?" she asked Frith.

Frith confirmed that the contracts included exit and transition provisions and that migration was "possible in principle.".

"However, given the requirement for a fresh iteration, given performance and the benefits already in play, and given the opportunity to add new capability, including maternity services, to a next generation of FDP, an 18 to 24-month period for commission and procurement is a reasonable assessment," he noted.

Recent findings suggest that technology and government priorities had moved on since the original FDP procurement in 2023, he told MPs. "We will begin a newly introduced procurement process along different lines from the current contract," he said.

The formal process is set to start during the second half of next year and take around 18 months.

It has been revealed that "Interoperability, resilience, and trusted common standards can and must be baked into the next generation of FDP. We will also start work, alongside the new procurement, with different providers on developing new capabilities and expertise starting with systems used in maternity care. Innovative providers will be invited to help address the data and digital fragmentation in this crucial area of care, and test how health priorities can create routes to build UK AI capability," Frith remarked.

Former Labour deputy leader Tom Watson, now Palantir's UK senior vice president, welcomed the extension.

"This is good news for patients and for the NHS. And it is the right decision to press forward with a programme that, in the words of Ministers, 'is significantly exceeding its benefits forecast and has exceeded every target' since it rolled out in 2024," he mentioned.

Industry observers note that "We will now redouble our efforts over the next two years to continue and accelerate that support. As a result of the announcement, we will also deepen our investment in the UK. The FDP is the right vehicle to deliver the change needed in the NHS, and over the next two years Palantir will do everything in its power to drive that change as far as possible, as fast as possible.".

Nonprofit tech transparency group Foxglove has challenged NHS contracts awarded to Palantir without competition since the pandemic, when the company initially offered its services for ยฃ1.

Responding to the extension, Foxglove co-executive director Rosa Curling mentioned:ย  "Palantir and its chief lobbyist Lord Tom Watson clearly think the contract extension is in the bag and appear to be already planning to turn that into another extension in two years, or a newly introduced procurement that heavily favors Palantir as we saw in 2023.

"The government must provide urgent clarity on whether they plan to help Watson embed Palantir in the NHS for the long term โ€“ or will kick this Trump-backing spy tech company out of the health service once and for all." ยฎ.

โ†’ Read original article